Tenax Therapeutics (TENX) Assets Average (2011 - 2026)

Tenax Therapeutics (TENX) has 14 years of Assets Average data on file, last reported at $113.7 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 8.94% year-over-year to $113.7 million; the trailing twelve-month figure through Mar 2026 stood at $113.7 million (up 8.94% YoY), and the FY2025 full-year result was $100.5 million, up 85.39% from the prior year.
• Assets Average rose to $113.7 million in Q1 2026, from $103.5 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $113.7 million in Q1 2026 to a low of $4.1 million in Q4 2022.
• A 5-year average of $46.1 million and a median of $13.1 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average tumbled 45.36% in 2022 and jumped 768.98% in 2025, its largest moves.
• Tracing TENX's Assets Average over 5 years: stood at $4.1 million in 2022, then soared by 189.47% to $11.8 million in 2023, then jumped by 733.42% to $98.2 million in 2024, then grew by 5.38% to $103.5 million in 2025, then advanced by 9.84% to $113.7 million in 2026.
• Business Quant data shows TENX's Assets Average at $113.7 million in Q1 2026, $103.5 million in Q4 2025, and $104.3 million in Q3 2025.